Ultrasound is more accurate than conventional screening for detecting goiter in patients on long-term lithium therapy, according to a recent study from Germany. Lithium therapy inhibits normal function of the thyroid, but clinical inspection and palpation missed goiter in some patients in whom it was detected with ultrasound.
Ultrasound is more accurate than conventional screening for detecting goiter in patients on long-term lithium therapy, according to a recent study from Germany. Lithium therapy inhibits normal function of the thyroid, but clinical inspection and palpation missed goiter in some patients in whom it was detected with ultrasound.
Dr. Michael Bauer and colleagues with the International Group for the Study of Lithium Treated Patients published the results of their study in the Journal of Affective Disorders in March. They recruited 96 consecutive patients from the Berlin Lithium Clinic. Some had been diagnosed with bipolar, major depressive, and schizoaffective diseases. As these patients often have trouble reliably taking their prescriptions, only those with adequate serum lithium levels documented continuously for at least six months were entered into the study.
As a control, exams for goiter were also performed on 96 subjects matching the gender and age of the lithium patients. Patients in both groups were at least 18 years old and residents of Berlin and surrounding areas.
Clinical inspection and palpation detected goiter in 24 of the lithium-treated patients, but ultrasound exams found 53 cases of goiter. This means that 54% of cases were overlooked by clinical inspection and palpation. In the control group, ultrasound detected 19 cases of goiter, while clinical inspection and palpation found 12 cases, so only 36% of cases were missed in this group.
A subgroup of the 96 patients on long-term lithium treatment were already taking levothyroxine, a thyroid hormone prescribed to treat hypothyroidism and goiter. Yet goiter was detected in 37% of patients in this subgroup. All patients who were not taking levothyroxine had significantly higher thyroid-stimulating hormone basal levels than did normal controls - a warning sign of thyroid disease.
This study did not control for other factors that might affect the prevalence of goiter, such as dietary issues, smoking, or iodine intake, and the patients on lithium were also being treated with additional psychotropic medications. The researchers concluded, however, that all patients on long-term lithium treatment should be regularly screened using ultrasound, to improve the early detection of goiter. Their study pointed out that other methods for detecting goiter are not sufficient for patients taking lithium long-term.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.